Treatment of steroid-resistant idiopathic nephrotic syndrome;Traitement du syndrome néphrotique idiopathique corticorésistant

Archives de Pediatrie

Volumn 16, Issue 3, 2009, Pages 260-268

  Chemli, J ^a   Harbi, A ^a  

^a SAHLOUL UNIVERSITY HOSPITAL   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ENALAPRIL; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PEFLOXACIN; PREDNISONE; STEROID; TACROLIMUS; VINCRISTINE SULFATE;

BLOOD TOXICITY; DRUG EFFICACY; GONADAL DISEASE; HUMAN; IDIOPATHIC DISEASE; NEPHROTIC SYNDROME; NEPHROTOXICITY; PLASMAPHERESIS; SHORT SURVEY;

ADRENAL CORTEX HORMONES; DRUG RESISTANCE; ENZYME INHIBITORS; HUMANS; IMMUNOSORBENT TECHNIQUES; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; NEPHROTIC SYNDROME; PLASMAPHERESIS;

EID: 60549104192     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2008.11.018     Document Type: Short Survey

References (50)

1. Obeidová H., Merta M., Reiterová J., et al. Genetic basis of nephrotic syndrome. Prague Med Rep 107 (2006) 5-16
2. Tune B.M., Kirpekar R., Sibley R.K., et al. Intravenous methylprednisolone and oral alkylating agent therapy of prednisone-resistant pediatric focal segmental glomerulosclerosis: a long-term follow-up. Clin Nephrol 43 (1995) 84-88
3. Mendoza S.A., Reznik M.V., Griswold R.W., et al. Treatment of steroid-resistant focal segmental glomerulosclerosis with pulse methyprednisolone and alkylating agents. Pediatr Nephrol 4 (1990) 303-307
4. Peña A., Bravo J., Melgosa M., et al. Steroid-resistant nephrotic syndrome: long-term evolution after sequential therapy. Pediatr Nephrol 22 (2007) 1875-1880
5. Bargman J.M. Management of minimal lesion glomerulonephritis: evidence-based recommendations. Kidney Int Suppl 70 (1999) S3-16
6. de Groot K., Adu D., and Savage C.O.S. The value of pulse cyclophosphamide in ANCA-associated vasculitis; meta-analysis and critical review. Nephrol Dial Transplant 16 (2001) 2018-2027
7. Elzouki A.Y., and Jaiswal O.P. Evaluation of chlorambucil therapy in steroid-dependent and cyclophosphamide-resistant children with nephrosis. Pediatr Nephrol 4 (1990) 459-462
8. Broyer M, Myrile A, Niaudet P et al. Minimal changes and focal segmental glomerulosclerosis in: Cameron; Si Davidson; Grunfeld JP; KerrD; Rtzteds. Oxfort Texbook of clinical Nephrology Oxfort Medical publication; 1992; pp 298-339.
9. Broyer M. La néphrose idiopathique de l'enfant et son traitement. Arch Fr Pediatr 45 (1988) 1-4
10. Hymes L.C. Steroid-resistant, cyclosporine-responsive, relapsing nephrotic syndrome. Pediatr Nephro 9 (1995) 137-139
11. Niaudet P. Treatment of childhood steroid-resistant idiopathic nephrosis with a combination of cyclosporine and prednisone. French Society of Pediatric Nephrology. J Pediatr 125 (1994) 981-986
12. Bagga A., Mudigoudar B.D., Hari P., et al. Enalapril dosage in steroid-resistant nephrotic syndrome. Pediatr Nephrol 19 (2004) 45-50
13. Hodson E.M., Habashy D., and Craig J.C. Interventions for idiopathic steroid resistant nephrotic syndrome in children. Cochrane Database Syst Rev 2 (2006) CD003594
14. Singh A., Tejani C., and Tejani A. One-center experience with cyclosporine in refractory nephrotic syndrome in children. Pediatr Nephrol 13 (1999) 26-32
15. Iijima K., Hamahira K., Tanaka R., et al. Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome. Kidney Int 61 (2002) 1801-1805
16. Seikaly M.G., Prashner H., Nolde-Hurlbert B., et al. Long-term clinical and pathological effect of cyclosporin in children with nephrosis. Pediatr Nephrol 14 (2000) 214-217
17. Mongeau J.G., Robitaille P.O., Clermont M.J., et al. Focal segmental glomerulosclerosis 20 years later: from toddler to grown-up. Clin Nephrol 40 (1993) 1-6
18. Bagga A., and Srivastava R.N. Nephrotic syndrome. In: Srivastava R.N., and Bagga A. (Eds). Pediatric Nephrology. 4th Ed. (2005), Jaypee, New Delhi 159-200
19. Rinaldi S., Sesto A., Barsotti P., et al. Cyclosporine therapy monitored with abbreviated area under curve in nephrotic syndrome. Pediatr Nephrol 20 (2005) 25-29
20. Schweda F., Liebl R., Riegger G.A., et al. Tacrolimus treatment for steroid- and cyclosporine-resistant minimal change nephrotic syndrome. Nephrol Dial Transplant 12 (1997) 2433-2435
21. Segarra A., Vila J., Pou L., et al. Combined therapy of tacrolimus and corticosteroids in cyclosporin-resistant or dependent idiopathic focal glomerulosclerosis: a preliminary uncontrolled study with prospective follow-up. Nephrol Dial Transplant 17 (2002) 655-662
22. Barletta G.M., Smoyer W.E., Bunchman T.E., et al. Use of mycophenolate mofetil in steroid-dependent and resistant nephrotic syndrome. Pediatr Nephrol 18 (2003) 833-837
23. Day C.J., Cockwell P., Lipkin G.W., et al. Mycophenolate mofetil in the treatment of resistant idiopathic nephrotic syndrome. Nephrol Dial Transplant 17 (2002) 2011-2013
24. Mendizabal S., Zamora I., Berbel O., et al. Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome. Pediatr Nephrol 20 (2005) 914-919
25. Abramowicz M., Barnett H.L., Edelmann Jr. C.M., et al. Controlled trial of azathioprine in children with nephrotic syndrome. A report for the international study of kidney disease in children. Lancet 1 (1970) 959-961
26. Ohtomo Y., Fujinaga S., Takada M., et al. High-dose mizoribine therapy for childhood-onset frequently relapsing steroid-dependent nephritic syndrome with cyclosporin nephrotoxicity. Pediatr Nephrol 20 (2005) 1744-1749
27. Yoshioka K., Ohashi Y., Sakai T., et al. A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome. Kidney Int 58 (2000) 317-324
28. Almeida M.P., Almeida H.A., and Rosa F.C. Vincristine in steroid resistant nephrotic syndrome. Pediatr Nephrol 8 (1994) 79-80
29. Goonasekera C.D., Koziell A.B., Hulton S.A., et al. Vincristine and focal segmental glomerulosclerosis: do we need a multicentre trial?. Pediatr Nephrol 12 (1998) 284-289
30. Feld S.M., Figueroa P., and Savin V. Plasmapheresis in the treatment of steroid-resistant focal segmental glomerulosclerosis in native kidneys. Am J Kidney Dis 32 (1998) 230-237
31. Mitwalli A.H. Adding plasmapheresis to corticosteroids and alkylating agents: does it benefit patients with focal segmental glomerulosclerosis?. Nephrol Dial Transplant 13 (1998) 1524-1528
32. Brewster U.C., and Perazella M.A. The renin-angiotensin aldosterone system and the kidney: effects on kidney disease. Am J Med 116 (2004) 263-272
33. Hannedouche T., Krummel T., and Parvez-Braun L. Néphroprotection. Comment ralentir l'évolution de l'insuffisance rénale chronique ?. Nephrol Ther 1 (2005) 135-144
34. Nakao N., Yoshimura A., Morita H., et al. Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (Cooperate): a randomised controlled trial. Lancet 361 (2003) 117-124
35. Sharma R., Sahu K., Gulati S., et al. Pefloxacin in steroid-dependent and resistant idiopathic nephrotic syndrome. J Nephrol 13 (2000) 271-274
36. Bertelli R., Ginevri F., Caridi G., et al. Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin. Am J Kidney Dis 41 (2003) 1314-1321
37. Niaudet P. Genetic forms of nephrotic syndrome. Pediatr Nephrol 19 (2004) 1313-1318
38. Ruf R.G., Lichterbenger A., Karle S.M., et al. Patients with mutation in NPHS2 (podocin) do not respond to steroid treatment of nephrotic syndrome. J Am Soc Nephrol 15 (2004) 722-732
39. Höcker B., Knüppel T., Waldherr R., et al. Recurrence of proteinuria 10 years post-transplantin NPHS2-associated focal segmental glomerulosclerosis after conversion from cyclosporin A to sirolimus. Pediatr Nephrol 21 (2006) 1476-1479
40. Bajpai A., Bagga A., Hari P., et al. Intravenous cyclophosphamide in steroid-resistant nephrotic syndrome. Pediatr Nephrol 18 (2003) 351-356
41. Cattran D.C., Appel G.B., Hebert L.A., et al. A randomized trial of cyclosporine in patients with steroid resistant focal segmental glomerulosclerosis. For the North America nephrotic syndrome study group. Kidney Int 56 (1999) 2220-2226
42. Gulati S., and Kher V. Intravenous pulse cyclophosphamide-a new regime for steroid-resistant focal segmental glomerulosclerosis. Indian Pediatr 37 (2000) 141-148
43. Nammalwar B.R., Vijayakumar M., Prahlad N., et al. Steroid-resistant nephrotic syndrome: is sustained remission attainable?. Indian Pediatr 43 (2006) 39-43
44. Savin V.J., Sharma R., Sharma M., et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 334 (1996) 878-883
45. Gagnadoux M.F., Broyer M., and Habib R. Transplantation in children with idiopathic nephrosis. In: Murakami K. (Ed). Recent advances in pediatric nephrology (1987), Elsevier Science Publishers, BV 351-356
46. Striegel J.E., Sibley R.K., Fryd D.S., et al. Recurrence of focal segmental sclerosis in children following renal transplantation. Kidney Int Suppl 19 (1986) S44-50
47. Salomon R., Gagnadoux M.F., and Niaudet P. Intravenous cyclosporine therapy in recurrent nephrotic syndrome after renal transplantation in children. Transplantation 75 (2003) 810-814
48. Dantal J., Baattard R., Hourmant M., et al. Recurrent nephrotic syndrome following renal transplantation in patients with focal glomerulosclerosis. A one-center study of plasma exchange effects. Transplantation 52 (1991) 827-831
49. Vehaskari V.M. Treatment practices of FSGS among North American paediatric nephrologists. Pediatr Nephrol 13 (1999) 301-303
50. Ulinski T., Perrin L., Guigonis V., et al. Remission of steroid- and CyA-resistant nephrotic syndrome using multiple drug immunosuppression. Pediatr Nephrol 22 (2007) 1723-1726